Economic Evaluation of Cancer Drugs by Iftekhar Khan

Economic Evaluation of Cancer Drugs by Iftekhar Khan

The first book on the design and analysis of not only clinical trials but also how observational non-interventional data using clinical data is applied to economic evaluation and re-imbursement in the context of Cancer. This book is a non technical exposition of economic evaluation and no knowledge of advanced statistical methods is assumed.

"This book is highly recommended for readers searching for an introductory text to the world of health economic analysisThe authors provide timely examples from both clinical trials in oncology and subsequent real-world application, discussing implications of findings and how they could potentially be applied to make future trials and real-world applications more efficient. ~Nuru Noor, ISCB News

Iftekhar Khan is a medical statistician and health economist and a lead statistician at Oxford Unviersity’s Center for Statistics in Medicine. Professor Khan is also a Senior Research Fellow in Health Economics at University of Warwick and is a Senior Statistical Assessor within the Licensing Division of the UK Medicine and Health Regulation Agency.

Ralph Crott is a former professor in Pharmacoeconomics at the University of Montreal in Quebec, Canada and former head of the EORTC Health Economics Unit and former senior health economist at the Belgian HTA organization.

Zahid Bashir has over twelve years experience working in the pharmaceutical industry in medical affairs and oncology drug development where he is involved in the design and execution of oncology clinical trials and development of reimbursement dossiers for HTA submission.

SKU	Unavailable
ISBN 13	9781498761307
ISBN 10	1498761305
Title	Economic Evaluation of Cancer Drugs
Author	Iftekhar Khan
Condition	Unavailable
Binding Type	Hardback
Publisher	Taylor & Francis Inc
Year published	2019-06-28
Number of pages	416
Cover note	Book picture is for illustrative purposes only, actual binding, cover or edition may vary.